top of page


Home: Welcome


A New Measure of Success for Your Premium IOL Patients


Introducing ClearView™ 3
The next-generation asymmetric multifocal refractive IOL now
FDA approved and available in the United States.
ClearView™ 3 is a rotationally asymmetric MIOL designed to improve contrast sensitivity, minimize halos and glare and provide superior near, intermediate and far vision compared to other presbyopic IOLs
​
The segmented optic design is the first of its kind in the US. Lenstec’s patented four-point fixation and design allows surgeons confidence in the IOLs effective lens position within the capsule. Its availability in 0.25 diopter power increments, along with the tightest industry tolerances (+/- 0.11 diopters from labelled power), assists surgeons in achieving the best refractive outcomes possible.

bottom of page